Silco Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	35.92	26.26	28.7	30.76	26.72	53.03
Short-Term Investments	-	-	1.77	18.97	37.91	19.41
Cash & Short-Term Investments	35.92	26.26	30.47	49.73	64.63	72.44
Cash Growth	-	-13.82%	-38.73%	-23.04%	-10.79%	-71.91%
Receivables	436.25	412.83	419.59	377.51	389.24	390.53
Inventory	459.56	450.67	444.1	444.14	457.84	449.45
Prepaid Expenses	-	0.59	0.59	-	0.21	0.21
Other Current Assets	123.78	126.95	160.19	133.55	136.83	139.59
Total Current Assets	1,056	1,017	1,055	1,005	1,049	1,052
Property, Plant & Equipment	1,739	1,743	1,767	1,762	1,671	1,643
Other Long-Term Assets	-	0	-	-0	-0	0
Total Assets	2,795	2,761	2,822	2,767	2,720	2,696
Accounts Payable	9.33	9.52	9.6	9.75	12.33	16.15
Accrued Expenses	11.47	10.48	9.18	9.27	16.93	21.21
Current Portion of Leases	2.52	4.99	4.26	-	4.11	3.77
Current Income Taxes Payable	196.46	188.97	285.19	273.7	255.21	240.41
Other Current Liabilities	2.16	2.17	2.56	3.04	2.33	1.42
Total Current Liabilities	221.94	216.13	310.8	295.76	290.91	282.96
Long-Term Leases	-	-	5.31	-	-	4.11
Long-Term Deferred Tax Liabilities	155.22	154.71	153.71	151.73	150.21	140.5
Other Long-Term Liabilities	0	-0	0	-0	-	0
Total Liabilities	377.15	370.84	469.82	447.5	441.11	427.57
Common Stock	1,038	1,038	1,038	1,038	1,038	1,038
Retained Earnings	1,379	1,352	1,316	1,289	1,251	1,230
Comprehensive Income & Other	-	-	-1.15	-6.92	-10.69	-0.37
Shareholders' Equity	2,417	2,390	2,352	2,320	2,279	2,268
Total Liabilities & Equity	2,795	2,761	2,822	2,767	2,720	2,696
Total Debt	2.52	4.99	9.57	-	4.11	7.89
Net Cash (Debt)	33.39	21.27	20.9	49.73	60.51	64.56
Net Cash Growth	-	1.76%	-57.97%	-17.82%	-6.26%	-74.97%
Net Cash Per Share	0.32	0.20	0.20	0.48	0.58	0.62
Filing Date Shares Outstanding	103.81	103.81	103.81	103.81	103.81	103.81
Total Common Shares Outstanding	103.81	103.81	103.81	103.81	103.81	103.81
Working Capital	833.57	801.16	744.14	709.17	757.83	769.27
Book Value Per Share	23.29	23.02	22.66	22.35	21.95	21.85
Tangible Book Value	2,417	2,390	2,352	2,320	2,279	2,268
Tangible Book Value Per Share	23.29	23.02	22.66	22.35	21.95	21.85
Land	-	74.85	74.85	74.85	74.85	74.85
Buildings	-	1,111	1,083	1,004	880.25	700.05
Machinery	-	1,609	1,576	1,524	1,443	1,320
Construction In Progress	-	137.32	128.1	174.96	197.38	394.59

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.